Investors Purchase High Volume of SPDR S&P Biotech ETF Put Options (NYSEARCA:XBI)

SPDR S&P Biotech ETF (NYSEARCA:XBI) was the target of unusually large options trading activity on Tuesday. Stock traders bought 59,636 put options on the company. This is an increase of 35% compared to the typical daily volume of 44,021 put options.

SPDR S&P Biotech ETF Trading Down 2.7%

Shares of NYSEARCA:XBI opened at $85.91 on Wednesday. The firm has a 50 day moving average of $82.17 and a 200-day moving average of $84.56. SPDR S&P Biotech ETF has a 12 month low of $66.66 and a 12 month high of $105.47. The stock has a market capitalization of $5.04 billion, a PE ratio of 11.47 and a beta of 0.97.

Institutional Inflows and Outflows

Several institutional investors have recently modified their holdings of the stock. Compass Ion Advisors LLC lifted its holdings in shares of SPDR S&P Biotech ETF by 3.9% during the second quarter. Compass Ion Advisors LLC now owns 3,727 shares of the exchange traded fund’s stock worth $309,000 after purchasing an additional 140 shares during the period. McAdam LLC raised its position in SPDR S&P Biotech ETF by 5.1% during the 2nd quarter. McAdam LLC now owns 3,273 shares of the exchange traded fund’s stock worth $271,000 after purchasing an additional 159 shares during the last quarter. Bourgeon Capital Management LLC lifted its holdings in SPDR S&P Biotech ETF by 6.1% during the 1st quarter. Bourgeon Capital Management LLC now owns 2,822 shares of the exchange traded fund’s stock worth $229,000 after buying an additional 163 shares during the period. First Heartland Consultants Inc. grew its position in shares of SPDR S&P Biotech ETF by 2.7% in the 1st quarter. First Heartland Consultants Inc. now owns 6,344 shares of the exchange traded fund’s stock valued at $514,000 after buying an additional 168 shares during the last quarter. Finally, Calton & Associates Inc. increased its stake in shares of SPDR S&P Biotech ETF by 3.2% in the first quarter. Calton & Associates Inc. now owns 5,662 shares of the exchange traded fund’s stock valued at $459,000 after buying an additional 175 shares during the period.

SPDR S&P Biotech ETF Company Profile

SPDR S&P Biotech ETF (the Fund) seeks to closely match the returns and characteristics of the S&P Biotechnology Select Industry Index. The S&P Biotechnology Select Industry Index represents the biotechnology sub-industry portion of the S&P Total Markets Index. The S&P TMI tracks all the United States common stocks listed on the New York Stock Exchange, American Stock Exchange, National Association of Securities Dealers Automated Quotation (NASDAQ) National Market and NASDAQ Small Cap exchanges.